Rolida, Ramel D.
HRN: 04-18-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2025
CLINDAMYCIN 300MG (CAP)
09/13/2025
09/15/2025
ORAL
600mg
Q8h
Cellulitis R Foot
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines